Lucifer Yellow(s)
Title: Lucifer Yellow(s)
Literature References: Water soluble fluorescent dyes. Description of properties and potential uses: W. W. Stewart, Cell 14, 741 (1978). Prepn: idem, J. Am. Chem. Soc. 103, 7615 (1981). Use in flux kinetics: C. L. Bowman, H. Tedeschi, Biochim. Biophys. Acta 731, 261 (1983); in intercellular communications: M. H. El-Fouly et al., Exp. Cell Res. 168, 422 (1987); as covalent marker: K. M. Lowe, R. E. McCarty, Biochemistry 37, 2507 (1998).
 
Derivative Type: Lucifer Yellow CH
CAS Registry Number: 67769-47-5
CAS Name: 6-Amino-2-[(hydrazinocarbonyl)amino]-2,3-dihydro-1,3-dioxo-1H-benz[de]isoquinoline-5,8-disulfonic acid dilithium salt
Additional Names: lucifer yellow carbohydrazide; 4-amino-N-[(hydrazinocarbonyl)amino]-2,3-naphthalimide-3,6-disulfonate
Molecular Formula: C13H9Li2N5O9S2
Molecular Weight: 457.25
Percent Composition: C 34.15%, H 1.98%, Li 3.04%, N 15.32%, O 31.49%, S 14.03%
Properties: Fluffy orange hygroscopic powder. uv max (water, excitation max): 280, 428 nm (e 24200, 11900); emission max: 540 nm. Quantum yield: 0.21.
Absorption maximum: uv max (water, excitation max): 280, 428 nm (e 24200, 11900)
 
Derivative Type: Lucifer Yellow VS
CAS Registry Number: 71231-14-6
CAS Name: 6-Amino-2-[3-(ethenylsulfonyl)phenyl]-2,3-dihydro-1,3-dioxo-1H-benz[de]isoquinoline-5,8-disulfonic acid dilithium salt
Additional Names: lucifer yellow vinylsulfone
Molecular Formula: C20H12Li2N2O10S3
Molecular Weight: 550.39
Percent Composition: C 43.64%, H 2.20%, Li 2.52%, N 5.09%, O 29.07%, S 17.48%
Properties: Crystals. uv max (water, excitation max): 280, 428 nm (e 24600, 12200); emission max: 540 nm. Quantum yield: 0.24.
Absorption maximum: uv max (water, excitation max): 280, 428 nm (e 24600, 12200)
 
Use: Fluoroprobe for biological tracing.

Others monographs:
Flurazepam3,4,6-Trichloro-2-nitrophenolMethaneAlexitol Sodium
Fluosol DAMethiotriazamineTolazamidePhenindamine
Allopregnane-3β,11β,17α,20β,21-pentolGold Tribromide2-(Ethylthio)ethanolTerlipressin
LaudanidineMaleic AnhydrideAraliaNoviflumuron
©2016 DrugLead US FDA&EMEA